Indian Billionaire Ajay Piramal’s $490M Pharma Stake Sale To Carlyle Will Help Him Pare Debt

by forbes.com posted 8months ago 33 views
In one of the largest private equity deals in the pharma sector in recent times listed Piramal Enterprises agreed to sell a 20% stake in its pharma subsidiary for $490 million to private equity firm, The Caryle Group.

In this article